421 related articles for article (PubMed ID: 33276146)
1. Mitochondrial oxidative function in NAFLD: Friend or foe?
Shum M; Ngo J; Shirihai OS; Liesa M
Mol Metab; 2021 Aug; 50():101134. PubMed ID: 33276146
[TBL] [Abstract][Full Text] [Related]
2. Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease.
Lee J; Park JS; Roh YS
Arch Pharm Res; 2019 Nov; 42(11):935-946. PubMed ID: 31571145
[TBL] [Abstract][Full Text] [Related]
3. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
[TBL] [Abstract][Full Text] [Related]
4. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
Dwivedi DK; Jena GB
Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
[TBL] [Abstract][Full Text] [Related]
5. Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease.
Fontes A; Alemany-Pagès M; Oliveira PJ; Ramalho-Santos J; Zischka H; Azul AM
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426291
[TBL] [Abstract][Full Text] [Related]
6. Potential roles of glucagon-like peptide-1-based therapies in treating non-alcoholic fatty liver disease.
Liu Y; Wei R; Hong TP
World J Gastroenterol; 2014 Jul; 20(27):9090-7. PubMed ID: 25083081
[TBL] [Abstract][Full Text] [Related]
7. 6-gingerol ameliorates age-related hepatic steatosis: Association with regulating lipogenesis, fatty acid oxidation, oxidative stress and mitochondrial dysfunction.
Li J; Wang S; Yao L; Ma P; Chen Z; Han TL; Yuan C; Zhang J; Jiang L; Liu L; Ke D; Li C; Yamahara J; Li Y; Wang J
Toxicol Appl Pharmacol; 2019 Jan; 362():125-135. PubMed ID: 30408433
[TBL] [Abstract][Full Text] [Related]
8. Ellagic Acid Alleviates Hepatic Oxidative Stress and Insulin Resistance in Diabetic Female Rats.
Polce SA; Burke C; França LM; Kramer B; de Andrade Paes AM; Carrillo-Sepulveda MA
Nutrients; 2018 Apr; 10(5):. PubMed ID: 29693586
[TBL] [Abstract][Full Text] [Related]
9. Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation.
Barbier-Torres L; Fortner KA; Iruzubieta P; Delgado TC; Giddings E; Chen Y; Champagne D; Fernández-Ramos D; Mestre D; Gomez-Santos B; Varela-Rey M; de Juan VG; Fernández-Tussy P; Zubiete-Franco I; García-Monzón C; González-Rodríguez Á; Oza D; Valença-Pereira F; Fang Q; Crespo J; Aspichueta P; Tremblay F; Christensen BC; Anguita J; Martínez-Chantar ML; Rincón M
Nat Commun; 2020 Jul; 11(1):3360. PubMed ID: 32620763
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum.
Yang XX; Wang X; Shi TT; Dong JC; Li FJ; Zeng LX; Yang M; Gu W; Li JP; Yu J
Biomed Pharmacother; 2019 Sep; 117():109083. PubMed ID: 31387169
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans.
Pafili K; Roden M
Mol Metab; 2021 Aug; 50():101122. PubMed ID: 33220492
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH.
Tan M; Mosaoa R; Graham GT; Kasprzyk-Pawelec A; Gadre S; Parasido E; Catalina-Rodriguez O; Foley P; Giaccone G; Cheema A; Kallakury B; Albanese C; Yi C; Avantaggiati ML
Cell Death Differ; 2020 Jul; 27(7):2143-2157. PubMed ID: 31959914
[TBL] [Abstract][Full Text] [Related]
14. Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction.
Xu L; Nagata N; Ota T
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775341
[TBL] [Abstract][Full Text] [Related]
15. Non-Alcoholic Fatty Liver Disease and Nutritional Implications: Special Focus on Copper.
Antonucci L; Porcu C; Iannucci G; Balsano C; Barbaro B
Nutrients; 2017 Oct; 9(10):. PubMed ID: 29057834
[TBL] [Abstract][Full Text] [Related]
16. Dihydromyricetin Ameliorates Nonalcoholic Fatty Liver Disease by Improving Mitochondrial Respiratory Capacity and Redox Homeostasis Through Modulation of SIRT3 Signaling.
Zeng X; Yang J; Hu O; Huang J; Ran L; Chen M; Zhang Y; Zhou X; Zhu J; Zhang Q; Yi L; Mi M
Antioxid Redox Signal; 2019 Jan; 30(2):163-183. PubMed ID: 29310441
[No Abstract] [Full Text] [Related]
17. Protocols for Mitochondria as the Target of Pharmacological Therapy in the Context of Nonalcoholic Fatty Liver Disease (NAFLD).
Grattagliano I; Di Ciaula A; Baj J; Molina-Molina E; Shanmugam H; Garruti G; Wang DQ; Portincasa P
Methods Mol Biol; 2021; 2310():201-246. PubMed ID: 34096005
[TBL] [Abstract][Full Text] [Related]
18. Swertiamarin ameliorates oleic acid induced lipid accumulation and oxidative stress by attenuating gluconeogenesis and lipogenesis in hepatic steatosis.
Patel TP; Rawal K; Soni S; Gupta S
Biomed Pharmacother; 2016 Oct; 83():785-791. PubMed ID: 27490779
[TBL] [Abstract][Full Text] [Related]
19. Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice.
Gan L; Meng ZJ; Xiong RB; Guo JQ; Lu XC; Zheng ZW; Deng YP; Luo BD; Zou F; Li H
Acta Pharmacol Sin; 2015 May; 36(5):597-605. PubMed ID: 25891086
[TBL] [Abstract][Full Text] [Related]
20. Imbalanced insulin substrate-1 and insulin substrate-2 signaling trigger hepatic steatosis in vitamin D deficient rats: 8-methoxypsoralen, a vitamin D receptor ligand with a promising anti-steatotic action.
Elhafiz M; Zhao G; Ismail M; Xu D; Das D; Fan S; Cheng N; Yousef BA; Jiang Z; Zhang L
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jun; 1865(6):158657. PubMed ID: 32045698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
